308 related articles for article (PubMed ID: 25967547)
1. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine-2,3-dioxygenase elevated in tumor-initiating cells is suppressed by mitocans.
Stapelberg M; Zobalova R; Nguyen MN; Walker T; Stantic M; Goodwin J; Pasdar EA; Thai T; Prokopova K; Yan B; Hall S; de Pennington N; Thomas SR; Grant G; Stursa J; Bajzikova M; Meedeniya AC; Truksa J; Ralph SJ; Ansorge O; Dong LF; Neuzil J
Free Radic Biol Med; 2014 Feb; 67():41-50. PubMed ID: 24145120
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.
Pasdar EA; Smits M; Stapelberg M; Bajzikova M; Stantic M; Goodwin J; Yan B; Stursa J; Kovarova J; Sachaphibulkij K; Bezawork-Geleta A; Sobol M; Filimonenko A; Tomasetti M; Zobalova R; Hozak P; Dong LF; Neuzil J
PLoS One; 2015; 10(5):e0119549. PubMed ID: 25932953
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria: An intriguing target for killing tumour-initiating cells.
Yan B; Dong L; Neuzil J
Mitochondrion; 2016 Jan; 26():86-93. PubMed ID: 26702582
[TBL] [Abstract][Full Text] [Related]
5. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrially targeted vitamin E succinate modulates expression of mitochondrial DNA transcripts and mitochondrial biogenesis.
Truksa J; Dong LF; Rohlena J; Stursa J; Vondrusova M; Goodwin J; Nguyen M; Kluckova K; Rychtarcikova Z; Lettlova S; Spacilova J; Stapelberg M; Zoratti M; Neuzil J
Antioxid Redox Signal; 2015 Apr; 22(11):883-900. PubMed ID: 25578105
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
9. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II.
Dong LF; Jameson VJ; Tilly D; Cerny J; Mahdavian E; Marín-Hernández A; Hernández-Esquivel L; Rodríguez-Enríquez S; Stursa J; Witting PK; Stantic B; Rohlena J; Truksa J; Kluckova K; Dyason JC; Ledvina M; Salvatore BA; Moreno-Sánchez R; Coster MJ; Ralph SJ; Smith RA; Neuzil J
J Biol Chem; 2011 Feb; 286(5):3717-28. PubMed ID: 21059645
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.
French R; Hayward O; Jones S; Yang W; Clarkson R
Mol Cancer; 2015 Dec; 14():209. PubMed ID: 26667821
[TBL] [Abstract][Full Text] [Related]
12. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH
Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842
[TBL] [Abstract][Full Text] [Related]
13. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
14. AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity.
Brantley E; Callero MA; Berardi DE; Campbell P; Rowland L; Zylstra D; Amis L; Yee M; Simian M; Todaro L; Loaiza-Perez AI; Soto U
Cancer Lett; 2016 Jun; 376(1):53-61. PubMed ID: 26996297
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
[TBL] [Abstract][Full Text] [Related]
16. Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice.
Parris AB; Zhao Q; Howard EW; Zhao M; Ma Z; Yang X
J Exp Clin Cancer Res; 2017 Feb; 36(1):28. PubMed ID: 28193239
[TBL] [Abstract][Full Text] [Related]
17. Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.
Rychtarcikova Z; Lettlova S; Tomkova V; Korenkova V; Langerova L; Simonova E; Zjablovskaja P; Alberich-Jorda M; Neuzil J; Truksa J
Oncotarget; 2017 Jan; 8(4):6376-6398. PubMed ID: 28031527
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy.
Kovarova J; Bajzikova M; Vondrusova M; Stursa J; Goodwin J; Nguyen M; Zobalova R; Pesdar EA; Truksa J; Tomasetti M; Dong LF; Neuzil J
Redox Rep; 2014 Jan; 19(1):16-25. PubMed ID: 24225203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]